Works matching IS 14611457 AND DT 2006 AND VI 9 AND IP 5

Results: 19

Does atypical antipsychotic medication improve executive function in schizophrenia? Bender et al. reply.

Published in:

International Journal of Neuropsychopharmacology, 2006, v. 9, n. 5, p. 631, doi. 10.1017/s1461145706007085

By:

Ulrich Schall;
Alexandra Dittmann-Balcar;
Stefan Bender

Publication type:

Article

Does atypical antipsychotic medication improve executive function in schizophrenia?

Published in:

International Journal of Neuropsychopharmacology, 2006, v. 9, n. 5, p. 629, doi. 10.1017/s1461145706007012

By:

Alex Collie;
Paul Maruff;
Peter J. Snyder

Publication type:

Article

The selective dopamine D3 receptor antagonist SB-277011A reduces nicotine-enhanced brain reward and nicotine-paired environmental cue functionsSome of the data presented in this article were previously presented, in abbreviated abstract form, at the 2003 and 2004 annual meeting of the Society for Neuroscience, at the 2004 annual meeting of the College on Problems of Drug Dependence, and at the 2004 annual meeting of the American College of Neuropsychopharmacology.

Published in:

International Journal of Neuropsychopharmacology, 2006, v. 9, n. 5, p. 585, doi. 10.1017/s1461145706006560

By:

Arlene C. Pak;
Charles R. Ashby;
Christian A. Heidbreder;
Maria Pilla;
Jeremy Gilbert;
Zheng-Xiong Xi;
Eliot L. Gardner

Publication type:

Article

Phenytoin, an anti-bipolar anticonvulsant: a potential anti-glucocorticoid mechanism?

Published in:

International Journal of Neuropsychopharmacology, 2006, v. 9, n. 5, p. 627, doi. 10.1017/s1461145705006450

By:

Peter Gallagher;
Keith S. Reid;
Stuart Watson

Publication type:

Article

Neuroleptic malignant syndrome induced by perospirone.

Published in:

International Journal of Neuropsychopharmacology, 2006, v. 9, n. 5, p. 635, doi. 10.1017/s1461145705006292

By:

Makiko Nakagawa;
Takehiko Matsumura;
Daiji Kato;
Ikuko Kishida;
Chiaki Kawanishi;
Kouichi Tamura;
Yoshio Hirayasu

Publication type:

Article

Elevated cerebrospinal fluid 5-hydroxyindoleacetic acid levels in women with comorbid depression and panic disorder.

Published in:

International Journal of Neuropsychopharmacology, 2006, v. 9, n. 5, p. 547, doi. 10.1017/s1461145705006231

By:

Gregory M. Sullivan;
Maria A. Oquendo;
Yung-yu Huang;
J. John Mann

Publication type:

Article

Lithium induces phosphoglucomutase activity in various tissues of rats and in bipolar patients.

Published in:

International Journal of Neuropsychopharmacology, 2006, v. 9, n. 5, p. 613, doi. 10.1017/s146114570500622x

By:

Péter Csutora;
Árpád Karsai;
Tamás Nagy;
Bálint Vas;
Gábor L. Kovács;
Orsolya Rideg;
Péter Bogner;
Attila Miseta

Publication type:

Article

Association between monoamine oxidase gene polymorphisms and smoking behaviour in Chinese males.

Published in:

International Journal of Neuropsychopharmacology, 2006, v. 9, n. 5, p. 557, doi. 10.1017/s1461145705006218

By:

Ying Jin;
Dafang Chen;
Yonghua Hu;
Song Guo;
Hongqiang Sun;
Aili Lu;
Xiaoyan Zhang;
Lingsong Li

Publication type:

Article

Duloxetine in the treatment of panic disorder.

Published in:

International Journal of Neuropsychopharmacology, 2006, v. 9, n. 5, p. 633, doi. 10.1017/s1461145705006206

By:

José Alexandre S. Crippa;
Antonio Waldo Zuardi

Publication type:

Article

ST 1535: a preferential A2A adenosine receptor antagonist.

Published in:

International Journal of Neuropsychopharmacology, 2006, v. 9, n. 5, p. 575, doi. 10.1017/s1461145705006188

By:

Maria Antonietta Stasi;
Franco Borsini;
Katia Varani;
Fabrizio Vincenzi;
Maria Assunta Di Cesare;
Patrizia Minetti;
Orlando Ghirardi;
Paolo Carminati

Publication type:

Article

Efficacy and safety of 30 mg/d and 45 mg/d nemifitide compared to placebo in major depressive disorder.

Published in:

International Journal of Neuropsychopharmacology, 2006, v. 9, n. 5, p. 517, doi. 10.1017/s1461145705006139

By:

Stuart A. Montgomery;
John P. Feighner;
Lev Sverdlov;
Ram K. Shrivastava;
Lynn A. Cunningham;
Ari Kiev;
Joseph Hlavka;
George Tonelli

Publication type:

Article

Donepezil effects on mood in patients with schizophrenia and schizoaffective disorder.

Published in:

International Journal of Neuropsychopharmacology, 2006, v. 9, n. 5, p. 603, doi. 10.1017/s1461145705006115

By:

S. Craig Risch;
Michael D. Horner;
Susan R. McGurk;
Simmy Palecko;
John S. Markowitz;
Ziad Nahas;
C. Lindsay DeVane

Publication type:

Article

The antipsychotic sultopride is overdosed – a PET study of drug-induced receptor occupancy in comparison with sulpiride.

Published in:

International Journal of Neuropsychopharmacology, 2006, v. 9, n. 5, p. 539, doi. 10.1017/s1461145705006103

By:

Akihiro Takano;
Tetsuya Suhara;
Fumihiko Yasuno;
Kazutoshi Suzuki;
Hidehiko Takahashi;
Takuya Morimoto;
Young-Joo Lee;
Hiroyuki Kusuhara;
Yuichi Sugiyama;
Yoshiro Okubo

Publication type:

Article

Decreased levels of whole blood glial cell line-derived neurotrophic factor (GDNF) in remitted patients with mood disorders.

Published in:

International Journal of Neuropsychopharmacology, 2006, v. 9, n. 5, p. 607, doi. 10.1017/s1461145705006085

By:

Minoru Takebayashi;
Kazue Hisaoka;
Akira Nishida;
Mami Tsuchioka;
Izuru Miyoshi;
Tosirou Kozuru;
Satoshi Hikasa;
Yasumasa Okamoto;
Hideto Shinno;
Shigeru Morinobu;
Shigeto Yamawaki

Publication type:

Article

Typical neuroleptics vs. atypical antipsychotics in the treatment of acute mania in a natural setting.

Published in:

International Journal of Neuropsychopharmacology, 2006, v. 9, n. 5, p. 529, doi. 10.1017/s1461145705006073

By:

Martin Letmaier;
Daniel Schreinzer;
Lutz Reinfried;
Georg Glauninger;
Nikolaus Thierry;
Thomas Kapitany;
Siegfried Kasper

Publication type:

Article

Treatment of behavioural, cognitive and circadian rest-activity cycle disturbances in Alzheimer's disease: haloperidol vs. quetiapine.

Published in:

International Journal of Neuropsychopharmacology, 2006, v. 9, n. 5, p. 507, doi. 10.1017/s1461145705006036

By:

Egemen Savaskan;
Corina Schnitzler;
Carmen Schröder;
Christian Cajochen;
Franz Müller-Spahn;
Anna Wirz-Justice

Publication type:

Article

A pharmacological modulation of opiate withdrawal using an up-/down-regulation of the noradrenergic system in opiate-dependent rats.

Published in:

International Journal of Neuropsychopharmacology, 2006, v. 9, n. 5, p. 621, doi. 10.1017/s1461145705006024

By:

Emmanuel Streel;
Bernard Dan;
Salvatore Campanella;
Alain Meyvaert;
Catherine Hanak;
Isy Pelc;
Paul Verbanck

Publication type:

Article

Prevention of relapse in generalized anxiety disorder by escitalopram treatment.

Published in:

International Journal of Neuropsychopharmacology, 2006, v. 9, n. 5, p. 495, doi. 10.1017/s1461145705005973

By:

Christer Allgulander;
Ioana Florea;
Anna K. Trap Huusom

Publication type:

Article

Clozapine and olanzapine, but not haloperidol, suppress serotonin efflux in the medial prefrontal cortex elicited by phencyclidine and ketamine.

Published in:

International Journal of Neuropsychopharmacology, 2006, v. 9, n. 5, p. 565, doi. 10.1017/s1461145705005900

By:

Mercè Amargós-Bosch;
Xavier López-Gil;
Francesc Artigas;
Albert Adell

Publication type:

Article